Mutational analysis of the Epstein-Barr virus nuclear antigen 2 by far-Western blotting and DNA-binding studies

Journal of General Virology

Volumn 77, Issue 5, 1996, Pages 991-996

  Sauder, Christian ^a   Götzinger, Nicole ^a   Schubach, William H ^b   Horvath, Gary C ^c   Kremmer, Elisabeth ^d   Krebs, Alexander ^a   König, Sigrid ^a   Zimber Strobl, Ursula ^d   Mueller Lantzsch, Nikolaus ^a   Grässer, Friedrich A ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c STONY BROOK UNIVERSITY   (United States)

^d INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS ANTIGEN; CELL PROTEIN; HISTONE H1; MUTANT PROTEIN; PROTEIN P130; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; B LYMPHOCYTE; CARBOXY TERMINAL SEQUENCE; CELL TRANSFORMATION; CONTROLLED STUDY; EPSTEIN BARR VIRUS; IMMUNOBLOTTING; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING;

HUMAN HERPESVIRUS 4;

EID: 9244252472     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-77-5-991     Document Type: Article

References (20)

1. BILLAUD, M., BUSSON, P., HUANG, D., MUELLER-LANTZSCH, N., ROUSSELET, G., PAVLISH, O., WAKASUGI, H., SEIGNEURIN, J. M , TURSZ, T. & LENOIR, G. M. (1989). Epstein-Barr virus (EBV)-containing nasopharyageal carcinoma cells express the B-cell activation antigen blast2/CD23 and low levels of the EBV receptor CR2. Journal of Virology 63, 4121-4128.
2. COHEN, J. I., WANG, F. & KIEFF, E. (1991). Epstein-Barr virus nuclear protein 2 mutations define essential domains for transformation and transactivation. Journal of Virology 65, 2545-2554.
3. GRÄSSER, F. A., HAISS, P., GÖTTEL, S. & MUELLER-LANTZSCH, N. (1991). Biochemical characterization of Epstein-Barr virus nuclear antigen 2A. Journal of Virology 65, 3779-3788.
4. GRÄSSER, F. A., SAUDER, C., HAISS, P., HILLE, A., KÖNIG, S., GÖTTEL, S., KREMMER, E., LEINENBACH, H. P., ZEPPEZAUER, M. & MUELLER-LANTZSCH, N. (1993). Immunological detection of proteins associated with the Epstein-Barr virus nuclear antigen 2A. Virology 195, 550-560.
5. HAMMERSCHMIDT, W. & SUGDEN, B. (1989). Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes. Nature 340, 393-397.
6. HENKEL, T , LING, P. D., HAYWARD, S. D. & PETERSON, M. G. (1994). Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein J kappa. Science 265, 92-95.
7. κ transcriptional repression domain by Epstein-Barr virus EBNA2. Science 268, 560-563.
8. KING, L. A. & POSSEE, R. D. (1992). The Baculovirus Expression System - A Laboratory Guide. London : Chapman & Hall.
9. KREMMER, E., KRANZ, B., HILLE, A., KLEIN, K., EULITZ, M., HOFFMANN-FEZER, G., FEIDEN, W., HERRMANN, K., DELECLUSE, H.-J., DELSOL, G., BORNKAMM, G. W., MUELLER-LANTZSCH, N & GRÄSSER, F. A. (1995). Rat monoclonal antibodies differentiating between the Epstein-Barr virus nuclear antigen 2A (EBNA2A) and 2B (EBNA2B). Virology 208, 336-342.
10. LAUX, G., ADAM, B., STROBL, L. J. & MOREAU-GACHELIN, F. (1994). The Spi-1/PU.1 and Spi-B ets family transcription factors and the recombination signal binding protein RBP-J kappa interact with an Epstein-Barr virus nuclear antigen 2 responsive cis-element. EMBO Journal 13, 5624-5632.
11. LING, P. D. & HAYWARD, S. D. (1995). Contribution of conserved amino acids in mediating the interaction between EBNA2 and CBF1/RBPκ. Journal of Virology 69, 1944-1950.
12. LING, P. D., HSIEH, J. J., RUF, I. K., RAWLINS, D. R. & HAYWARD, S D. (1994). EBNA-2 upregulation of Epstein-Barr virus latency promoters and the cellular CD23 promoter utilizes a common targeting intermediate, CBF1. Journal of Virology 68, 5375-5383.
13. MIDDLETON, T., GAHN, T. A., MARTIN, J. M. & SUGDEN, B. (1991). Immortalizing genes of Epstein-Barr virus. Advances in Virus Research 40, 19-55.
14. MILLER, G. (1990). Epstein-Barr virus: biology, pathogenesis and medical aspects. In Virology, 2nd edn, pp. 1921-1958. Edited by B. N. Fields & D. M. Knipe. New York: Raven Press.
15. RING, J. A. (1994). The B cell-immortalizing functions of Epstein-Barr virus. Journal of General Virology 75, 1-13.
16. SAUDER, C., HAISS, P., GRÄSSER, F. A., ZIMBER-STROBL, U. & MUELLER-LANTZSCH. N. (1994). DNA-binding studies of the Epstein-Barr virus nuclear antigen 2 (EBNA-2) : evidence for complex formation by latent membrane protein gene promoter-binding proteins in EBNA-2-positive cell lines. Journal of General Virology 75, 3067-3079.
17. TONG, X., YALAMANCHILI, R., HARADA, S. & KIEFF, E. (1994). The EBNA-2 arginine-glycine domain is critical but not essential for B-lymphocyte growth transformation; the rest of region 3 lacks essential interactive domains. Journal of Virology 68, 6188-6197.
18. TONG, X., DRAPKIN, R., YALAMANCHILI, R., MOSIALOS, G. & KIEFF, E. (1995). The Epstein-Barr virus nuclear protein 2 acidic domain forms a complex with a novel cellular coactivator that can interact with TFIIE. Molecular and Cellular Biology 15, 4735-4744.
19. TSUI, S. & SCHUBACH, W. H. (1994). Epstein-Barr virus nuclear protein 2A forms oligomers in vitro and in vivo through a region required for B-cell transformation. Journal of Virology 68, 4287-4294.
20. κ, the homologue of Drosophila suppressor of hairless. EMBO Journal 13, 4973-4982.